NASDAQ: OPRX Investor Information

A digital health platform for medication affordability and adherence - connecting pharma to providers, patients, payers, and pharmacies

REASONS TO INVEST

 

OptimizeRx, a digital health communications platform, exists to solve real challenges in healthcare at a time when it's needed more than ever.

We have multiple solutions to help our clients communicate with their clients and to help doctors and patients engage in a smoother and more effective care continuum by impacting both affordability and adherence for better outcomes.

Green_Carrot Deductibles are up 200% since 2008

Green_Carrot Medication adherence is a $528 billion dollar problem

Green_Carrot Over 50% of doctors' offices and clinics won't let reps in

Green_Carrot 90% of U.S. physicians are now using an EHR on a daily basis with average daily use of approximately 5.9 hours per day spent

OptimizeRx (Nasdaq: OPRX) continues to make news and drive innovation to improve medication affordability and adherence.

You can see a few of our most recent news and media mentions below. View our full Investor site here.  

Exciting Things Are Happening - Subscribe for Updates and News

OPRX

Upcoming Conferences and Speaking Engagements

 

Industry

MGMA in New Orleans, LA - 10/13-10/16/19 

HLTH in Las Vegas, NV - 10/27-10/30/19

2019 Fall Hospital Pharmacy Conference, Kansas City, MO - 10/28-10/30/19

MM&M #TrendTalks, NYC, 11/07/19 - Invite-Only Industry Leaders Panel. If interested, email OPRXconnects@optimizerx.com

HIMSS20 in Orlando, FL - 3/9-3/13/20

Future Pharma in Boston, MA - 09/14-09/15/20

If you'll be at any of these conferences, and want to connect, please send an email to OPRXconnects@optimizerx.com.

 

LATEST

Q2 2019 Results

On August 8, 2019, we announced our quarterly earnings.

You can listen to the full call through 8/28/2019:

Toll-free replay number: 1-844-512-2921
International replay number: 1-412-317-6671
Replay ID: 1609655

Download our latest Corporate Presentation here.

%_Icon

Revenue - $7 Million - an increase of 37%

Dollar_Sign_Smaller

On a GAAP basis, net income was $407,000 or$0.03 a share

Patient_Engage_Green

Added several positions to increase Commercial and Hospital/Health System reach

Growth

Ninth straight quarter of revenue growth

OptimizeRx News & Resources Updates

Explore

View full OPRX Investor Site

Visit Now